This post is from a suggested group
🔎 Technological Leap in Breast Cancer Screening: The Digital Breast Tomosynthesis (DBT) Market Evolution
The Digital Breast Tomosynthesis (DBT) Market, also known as 3D mammography, is experiencing robust growth driven by its proven superiority over traditional 2D mammography, particularly in the early detection of breast cancer. DBT provides a series of high-resolution images of the breast from multiple angles, which are then reconstructed into a three-dimensional image. This capability effectively minimizes the issue of overlapping tissue, a common limitation of 2D imaging, leading to higher cancer detection rates and a reduction in false positives and unnecessary callbacks, especially for women with dense breast tissue. The escalating global incidence of breast cancer and increasing governmental and organizational mandates for screening programs are the primary market accelerators. Favorable reimbursement policies, combined with the growing awareness among both clinicians and patients about the benefits of 3D imaging, are pushing the accelerated adoption of…
